Blonder Tongue Laboratories Inc
BDR was delisted on the 24th of June, 2022.
7 hedge funds and large institutions have $638K invested in Blonder Tongue Laboratories Inc in 2021 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
3% more capital invested
Capital invested by funds: $622K → $638K (+$16K)
22% less funds holding
Funds holding: 9 → 7 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tufton Capital Management
Hunt Valley,
Maryland
|
+$297K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$119K |
| 3 |
Renaissance Technologies
New York
|
+$13.6K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$9 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$424K |
| 2 |
VF
Virtu Financial
New York
|
-$20K |
| 3 |
Two Sigma Advisers
New York
|
-$15.5K |
| 4 |
TSS
Two Sigma Securities
New York
|
-$14K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TCM
1
Tufton Capital Management
Hunt Valley,
Maryland
| $277K | +$297K | +188,940 | New |
|
|
2
Citadel Advisors
Miami,
Florida
| $129K | +$119K | +75,853 | +630% |
|
|
3
Renaissance Technologies
New York
| $120K | +$13.6K | +8,654 | +12% |
|
|
BCM
4
Bridgeway Capital Management
Houston,
Texas
| $59K | -$424K | -270,100 | -87% |
|
|
5
Two Sigma Advisers
New York
| $29K | -$15.5K | -9,900 | -33% |
|
6
Vanguard Group
Malvern,
Pennsylvania
| $24K | – | – | – |
|
|
VF
7
Virtu Financial
New York
| – | -$20K | -15,059 | Closed |
|
|
TSS
8
Two Sigma Securities
New York
| – | -$14K | -10,570 | Closed |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$1K | -591 | Closed |
|
|
10
Wells Fargo
San Francisco,
California
| – | +$9 | +6 | +29% |
|
BDR Hedge Fund Activity: Q1 2021 in Review
7 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Blonder Tongue Laboratories Inc (BDR) for Q1 2021, worth a combined $638K — up 2.6% from $622K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of BDR and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 3 added.
The largest buyer was Tufton Capital Management, opening a new position worth an estimated $297K. The largest seller was Bridgeway Capital Management, cutting an estimated $424K.
- 7 institutional investors held Blonder Tongue Laboratories Inc (BDR) as of Q1 2021, down from 9 in Q4 2020.
- Funds reported $638K of Blonder Tongue Laboratories Inc stock for Q1 2021, up 2.6% quarter-over-quarter.
- 1 fund opened new Blonder Tongue Laboratories Inc positions in Q1 2021 and 3 closed out, a net change of -2 holders.
- The largest Blonder Tongue Laboratories Inc buyer in Q1 2021 was Tufton Capital Management, an estimated $297K added.
- The largest Blonder Tongue Laboratories Inc seller in Q1 2021 was Bridgeway Capital Management, an estimated $424K sold.
Based on aggregated 13F filings for Q1 2021.